Treatment of cytarabine acral erythema with corticosteroids.
Brown
J
J
Department of Pharmacy Practice, University of Washington Medical Center, Seattle 98195.
Burck
K
K
Black
D
D
Collins
C
C
D000328:Adult; D003561:Cytarabine / Q000009:adverse effects*; D004890:Erythema / Q000139:chemically induced / Q000188:drug therapy*; D005148:Facial Dermatoses / Q000139:chemically induced / Q000188:drug therapy*; D005533:Foot Dermatoses / Q000139:chemically induced / Q000188:drug therapy; D006229:Hand Dermatoses / Q000139:chemically induced / Q000188:drug therapy*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D011241:Prednisone / Q000627:therapeutic use*
D003561:Cytarabine; D011241:Prednisone